A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease
Clinical trial NCT05521191 · COMPLETED
Trial details
- NCT number
- NCT05521191
- Sponsor
- Regulus Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-06
- Primary completion
- 2025-01-27
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.